A5092825666- Liver Disease Diagnosis and Treatment
- Aortic Disease and Treatment Approaches
- Atrial Fibrillation Management and Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac Valve Diseases and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Aortic aneurysm repair treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Lipoproteins and Cardiovascular Health
- MicroRNA in disease regulation
- Hip and Femur Fractures
- Systemic Lupus Erythematosus Research
- Global Health Workforce Issues
- Hepatitis C virus research
- Coenzyme Q10 studies and effects
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Disease Management Strategies
- Hepatocellular Carcinoma Treatment and Prognosis
- Genomics and Rare Diseases
- Sarcoidosis and Beryllium Toxicity Research
- Global Health Care Issues
- Cardiovascular Syncope and Autonomic Disorders
- Cardiac pacing and defibrillation studies
- Advanced battery technologies research
Yale University
2024-2025
Bolan University of Medical and Health Sciences
2023-2025
Yale New Haven Hospital
2025
University of Balochistan
2024
Institute of Medical Sciences
2024
Introduction Sarcoidosis is an inflammatory disease characterized by granulomas, the etiology of which remains unclear. This study examines sarcoidosis-related mortality trends in United States from 1999 to 2020, with a focus on disparities pertaining patient sex, geographical location, and urbanization status. Methods We analyzed death certificate data CDC WONDER database, using ICD-10 code D86. Age-adjusted rates (AAMR) per 1,000,000 people were calculated. Trends Joinpoint regression...
Background Chronic obstructive pulmonary disease (COPD) and cardiovascular (CVD) greatly influence morbidity mortality, with COPD patients frequently suffering from comorbidities like coronary heart stroke. This study analyzes mortality trends disparities among individuals in the United States (US) affected by both CVD COPD. Methods analyzed death certificates CDC WONDER database for aged 25 older who died between 1999 2020 (ICD I00-I99) J41-J44). Age-adjusted rates (AAMRs) annual percent...
Background Paroxysmal tachycardia encompasses various heart rhythm disorders that cause rapid rates. Its episodic occurrence makes it difficult to identify and measure its prevalence trends in the population. Additionally, there is limited data on disparities mortality due paroxysmal tachycardia, which essential for assessing current medical approaches identifying at-risk populations. Methods Our study examined death certificates from 1999 2020 using CDC WONDER Database deaths caused by...
Introduction Bempedoic acid (BA) has shown varied efficacy in managing hyperlipidemia. We conducted the most extensive up-to-date meta-analysis, first to include recent studies by Nissen et al., which boast largest sample size. Methods Literature search was done on Medline, EMBASE, and Cochrane Library. The primary endpoint a change low-density lipoprotein-cholesterol (LDL-C) levels, while secondary endpoints encompassed changes lipid parameters, clinical endpoints, safety endpoints....
Key Clinical Message Ruptured sinus of Valsalva (RSOV) upon physical exertion is rare but should be considered in differential young adults. Symptoms acute heart failure, hemodynamic instability, and continuous murmur raises suspicion for RSOV requires emergent surgical repair right ventricular outflow tract.
Background: Thoracic aortic aneurysms (TAA) impact approximately 6 to 10 individuals per 100,000 people, though the actual prevalence is likely higher due frequent asymptomatic presentations, posing a challenge for early diagnosis. The rupture of these presents significant risk, resulting in an estimated 30,000 deaths annually United States alone. This emphasizes urgent need enhanced detection and treatment strategies. An understanding trends TAA mortality imperative assessing efficacy...
Background: Screening studies have reported a prevalence of 3-8% for abdominal aortic aneurysms (AAA). Despite positive trend decline over the past two decades, mortality linked to AAA remains significant public health concern. In United States alone, complications resulted in an estimated 13,640 deaths between 2018 and 2021. Thus, understanding trends disparities is crucial evaluating effectiveness current approaches identifying vulnerable populations. Methods: This study analyzed death...
Viral hepatitis is a significant public health concern worldwide. It has disproportionately impacted millions of people around the globe. With high prevalence 257 million for chronic B and 71 C, viral remains one leading causes death (1.1 deaths 3.0 new infections per year) globally all hepatotropic viruses, Hepatitis C Virus (HCV) constitutes disease burden as it clinically silent undiagnosed years